↓ Skip to main content

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
11 X users

Citations

dimensions_citation
241 Dimensions

Readers on

mendeley
210 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Published in
Journal for Immunotherapy of Cancer, November 2018
DOI 10.1186/s40425-018-0442-7
Pubmed ID
Authors

Vivek Verma, Tanja Sprave, Waqar Haque, Charles B. Simone, Joe Y. Chang, James W. Welsh, Charles R. Thomas

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 210 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 39 19%
Student > Master 22 10%
Student > Bachelor 21 10%
Student > Ph. D. Student 17 8%
Other 15 7%
Other 24 11%
Unknown 72 34%
Readers by discipline Count As %
Medicine and Dentistry 43 20%
Pharmacology, Toxicology and Pharmaceutical Science 19 9%
Biochemistry, Genetics and Molecular Biology 17 8%
Agricultural and Biological Sciences 11 5%
Immunology and Microbiology 10 5%
Other 33 16%
Unknown 77 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2020.
All research outputs
#1,378,250
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#346
of 3,424 outputs
Outputs of similar age
#31,001
of 446,197 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#8
of 59 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.